Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3768291014 | Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3779253018 | Carglumic acid 200 mg tablet for oral suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4669621000052114 | kargluminsyra 200 milligram, tablett till oral suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has manufactured dose form | Tablet for oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Carglumic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has precise active ingredient | Carglumic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | har täljarvärde som visar styrka | 200 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Is a | Carglumic acid only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR